Skip to main content
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis logoLink to Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
letter
. 2012 Jan-Feb;32(1):113–114. doi: 10.3747/pdi.2011.00038

Recurrent Peritonitis Episodes in a Continuous Ambulatory Peritoneal Dialysis Patient After Gynecologic Procedures

TL Ma 1, CT Wang 1, JC Hwang 1,*
PMCID: PMC3525377  PMID: 22302931

Editor:

Few reports have discussed the transvaginal mechanism of infection in continuous ambulatory peritoneal dialysis (CAPD)–related peritonitis. Here, we present the case of a woman with end-stage renal disease on CAPD experiencing recurrent episodes of peritonitis after gynecologic procedures.

A 41-year-old woman had been on CAPD since 2004 because of immunoglobulin A nephropathy. In April 2009, a Pap smear resulted in a report of cervical intraepithelial neoplasia grade III. The patient underwent cervical conization and endocervical curettage under colposcopy. About 2 weeks later, she experienced the first episode of peritonitis, with the dialysate culture being positive for Stenotrophomonas maltophilia. This peritonitis was successfully treated with intraperitoneal (IP) cefazolin 200 mg and gentamicin 8 mg in each bag for the first 3 days, and then with IP ciprofloxacin 100 mg in the last daily bag for the next 12 days.

After 9 months, the patient underwent a follow-up Pap smear. On the day after that test, she found cloudy effluent, which revealed a white cell count of 1168/μL, with 100% neutrophils. Dialysate culture yielded Streptococcus viridans. This peritonitis subsided after treatment with IP cefazolin and gentamicin for 2 weeks. However, 2 weeks later, another episode of culture-negative peritonitis occurred. The Tenckhoff catheter was removed, and the patient was temporarily switched to hemodialysis for 1 month because of treatment failure after 2 weeks of vancomycin.

In October 2010, the patient had another Pap smear, and again, the dialysis effluent became cloudy on the following day. Effluent analysis revealed a white cell count of 663/μL with 99% neutrophils. Cultures of effluent and blood were negative. This episode of peritonitis was successfully treated with 2 weeks of IP cefazolin 200 mg and gentamicin 8 mg in each bag.

DISCUSSION

In our patient, the first episode of peritonitis, caused by Steno. maltophilia, occurred 2 weeks after conization. This bacterium is a common environmental saprophyte isolated from water, soil, foods, and hospital equipment (1). Peritonitis from Steno. maltophilia often occurs in PD patients with comorbidities or in those on immunosuppressants (1,2). We can not exclude the possibility of introduction of the bacterium through the manipulated cervix.

The second episode of peritonitis was caused by Strep. viridans. The most common source of Strep. viridans is the oral cavity (3). Cases of Strep. viridans peritonitis have been reported in PD patients after dental surgery (4) and gastroscopy (5). The clinical course is benign, but the recurrence rate is high (3). Our patient underwent neither a dental procedure nor endoscopy before the peritonitis. The source of the Strep. viridans is probably related to the Pap smear procedure. This bacterium is also normal flora in the vagina (6).

Our patient experienced 3 episodes of peritonitis. One followed the colposcopy and conization, and the other two occurred after a Pap smear. The transvaginal route is one of the possible mechanisms. We hypothesize that the conization might have changed the cervical microflora and anatomy, which resulted in the first peritonitis, and that the subsequent episodes of peritonitis were precipitated by the Pap smears. The prescription of antibiotics before dental procedures (4) and gastroscopy (5) in PD patients has been suggested in previous reports. We suggest that CAPD patients might benefit from antibiotic prophylaxis before gynecologic procedures such as Pap smears and conization. Further studies are required for clarification.

DISCLOSURES

The authors have no conflicts of interest to disclose.

REFERENCES

  • 1. Taylor G, McKenzie M, Buchanan–Chell M, Perry D, Chui L, Dasgupta M. Peritonitis due to Stenotrophomonas maltophilia in patients undergoing chronic peritoneal dialysis. Perit Dial Int 1999; 19:259–62 [PubMed] [Google Scholar]
  • 2. Baek JE, Jung EY, Kim HJ, Lee GW, Hahm JR, Kang KR, et al. Stenotrophomonas maltophilia infection in patients receiving continuous ambulatory peritoneal dialysis. Korean J Intern Med 2004; 19:104–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Shukla A, Abreu Z, Bargman JM. Streptococcal PD peritonitis—a 10-year review of one centre’s experience. Nephrol Dial Transplant 2006; 21:3545–9 [DOI] [PubMed] [Google Scholar]
  • 4. Kiddy K, Brown PP, Michael J, Adu D. Peritonitis due to Streptococcus viridans in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) 1985; 290:969–70 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Machuca E, Ortiz AM, Rabagliati R. Streptococcus viridans–associated peritonitis after gastroscopy. Adv Perit Dial 2005; 21:60–2 [PubMed] [Google Scholar]
  • 6. Hammann R. A reassessment of the microbial flora of the female genital tract, with special reference to the occurrence of Bacteroides species. J Med Microbiol 1982; 15:293–302 [DOI] [PubMed] [Google Scholar]

Articles from Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis are provided here courtesy of Multimed Inc.

RESOURCES